Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/123453
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Higher serum sex hormone-binding globulin levels are associated with incident cardiovascular disease in men |
Author: | Gyawali, P. Martin, S.A. Heilbronn, L.K. Vincent, A.D. Jenkins, A.J. Januszewski, A.S. Adams, R.J.T. O'Loughlin, P.D. Wittert, G.A. |
Citation: | Journal of Clinical Endocrinology and Metabolism, 2019; 104(12):6301-6315 |
Publisher: | Oxford University Press |
Issue Date: | 2019 |
ISSN: | 0021-972X 1945-7197 |
Statement of Responsibility: | Prabin Gyawali, Sean A. Martin, Leonie K. Heilbronn, Andrew D. Vincent, Alicia J. Jenkins, Andrzej S. Januszewski, Robert J.T. Adams, Peter D. O’Loughlin, and Gary A. Wittert |
Abstract: | Context: Sex hormone-binding globulin (SHBG) levels are associated with cardiovascular disease (CVD) risk factors. However, prospective data on the association between SHBG levels and CVD events are sparse, with conflicting results. Objectives: To examine associations between serum SHBG, total testosterone (TT), and incident CVD and CVD-related mortality in middle-aged to elderly men. Design and Methods: Data on 2563 community-dwelling men (35-80 years) were obtained from participants in the Men Androgen Inflammation Lifestyle Environment and Stress (MAILES) cohort. The analytic sample included 1492 men without baseline (2002-2007) CVD and with fasted morning serum SHBG and TT available at both baseline and follow-up (2007-2010), and without medications affecting TT or SHBG. Associations of baseline SHBG and TT, with incident CVD and CVD - mortality, were analysed using logistic regression for incident CVD and Cox's proportional hazard regression for CVD mortality, adjusting for established CVD risk factors. Results: In multivariable models, elevated baseline SHBG and lower baseline TT were independently associated with incident CVD (OR=1.54 [1.15, 2.06] per SD increase in SHBG, p=0.003) and (OR =0.71 [0.52, 0.97] per SD decrease in TT, p=0.03), respectively. A decrease in TT between time points was associated with incident CVD (OR=0.72 [0.56, 0.92], P=0.01). Neither SHBG nor TT were significantly associated with all-age CVD mortality (HR=0.69 [0.29, 1.63], p=0.40 & HR=0.60 [0.28, 1.26], p=0.18, respectively). Conclusions: Among all men and men aged over 65, both elevated SHBG and lower TT were independently associated with both a greater risk of CVD and an increased CVD mortality risk. |
Keywords: | Humans Cardiovascular Diseases Sex Hormone-Binding Globulin Prognosis Incidence Mortality Survival Rate Follow-Up Studies Prospective Studies Adult Aged Aged, 80 and over Middle Aged Australia Male Biomarkers |
Rights: | Copyright © 2019 Endocrine Society |
DOI: | 10.1210/jc.2019-01317 |
Grant ID: | http://purl.org/au-research/grants/nhmrc/627227 |
Published version: | http://dx.doi.org/10.1210/jc.2019-01317 |
Appears in Collections: | Aurora harvest 4 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.